The DOI matches its Crossref record; 255 of the 255 references it cites were found in a registry or an index.
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Open accessAbstract
With the recent FDA approval of the first siRNA‐derived therapeutic, RNA interference (RNAi)‐mediated gene therapy is undergoing a transition from research to the clinical space. The primary obstacle to realization of RNAi therapy has been the delivery of oligonucleotide payloads. Therefore, the main aims is to identify and describe key design features needed for nanoscale vehicles to achieve effective delivery of siRNA‐mediated gene silencing agents in vivo. The problem is broken into three elements: 1) protection of siRNA from degradation and clearance; 2) selective homing to target cell types; and 3) cytoplasmic release of the siRNA payload by escaping or bypassing endocytic uptake. The in vitro and in vivo gene silencing efficiency values that have been reported in publications over the past decade are quantitatively summarized by material type (lipid, polymer, metal, mesoporous silica, and porous silicon), and the overall trends in research publication and in clinical translation are discussed to reflect on the direction of the RNAi therapeutics field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–255 of 255
Gu, H., Chen, Y., Wang, X., Liu, T., Zhang, D. S., Wang, Y., & Di, W. J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s78774 · Cited by 78
Bottlebrush-architectured poly(ethylene glycol) as an efficient vector for RNA interference in vivo
Wang, D., Lin, J., Jia, F., Tan, X., Wang, Y., Sun, X., Cao, X., Che, F., Lü, H., Gao, X., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav9322 · Cited by 75
Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK
Paolo, D. D., Brignole, C., Pastorino, F., Carosio, R., Zorzoli, A., Rossi, M., Loi, M., Pagnan, G., Emionite, L., Cilli, M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.54 · Cited by 74
Liposome-polyethylenimine complexes (DPPC-PEI lipopolyplexes) for therapeutic siRNA delivery in vivo
Ewe, A., Panchal, O., Pinnapireddy, S. R., Bakowsky, U., Przybylski, S., Temme, A., & Aigner, A. M. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.08.005 · Cited by 74
Morry, J., Ngamcherdtrakul, W., Gu, S., Goodyear, S. M., Castro, D. J., Reda, M. M., Sangvanich, T., & Yantasee, W. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.005 · Cited by 73
Futaki, S., Masui, Y., Nakase, I., Sugiura, Y., Nakamura, T., Kogure, K., & Harashima, H. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.796 · Cited by 73
Butler, M., Crooke, R. M., Graham, M. J., Lemonidis, K. M., Lougheed, M., Murray, S. F., Witchell, D. R., Steinbrecher, U. P., & Bennett, C. F. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35317-0 · Cited by 72
Chemical modification resolves the asymmetry of siRNA strand degradation in human blood serum
Hoerter, J. A. H., & Walter, N. G. (2007) · RNA · doi:10.1261/rna.602307 · Cited by 71
Role of antibodies in cancer targeting
Attarwala, H. Z. (2010) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.71675 · Cited by 68
Finlay, J. B., Roberts, C. M., Dong, J. I., Zink, J. I., Tamanoi, F., & Glackin, C. A. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.05.011 · Cited by 66
Dupont, E., Prochiantz, A., & Joliot, A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-919-2_2 · Cited by 66
Morry, J., Ngamcherdtrakul, W., Gu, S., Reda, M. M., Castro, D. J., Sangvanich, T., Gray, J. W., & Yantasee, W. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0644 · Cited by 64
Riley, R., Dang, M. N., Billingsley, M. M., Abraham, B., Gundlach, L., & Day, E. S. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00681 · Cited by 64
Calcium phosphate nanoparticles-based systems for siRNA delivery
Xu, X., Li, Z., Zhao, X., Keen, L. J., & Kong, X. (2016) · Regenerative Biomaterials · doi:10.1093/rb/rbw010 · Cited by 61
Ni, S., Liu, Y., Tang, Y., Chen, J., Li, S., Pu, J., & Han, L. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.09.075 · Cited by 61
Targeted drug delivery using iRGD peptide for solid cancer treatment
Liu, X., Jiang, J., Ji, Y. C., Lu, J., Chan, R., & Meng, H. (2017) · Molecular Systems Design & Engineering · doi:10.1039/c7me00050b · Cited by 60
Tangsangasaksri, M., Takemoto, H., Naito, M., Maeda, Y., Sueyoshi, D., Kim, H. J., Miura, Y., Ahn, J., Azuma, R., Nishiyama, N., et al. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01334 · Cited by 59
Montgomery, M. K. (2004) · Humana Press eBooks · doi:10.1385/1-59259-775-0:003 · Cited by 58
Zhang, W., Müller, K., Kessel, E., Reinhard, S., He, D., Klein, P. M., Höhn, M., Rödl, W., Kempter, S., & Wagner, E. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600057 · Cited by 57
Wagenaar, T. R., Tolstykh, T., Shi, C., Jiang, L., Zhang, J., Li, Z., Yu, Q., Qu, H., Sun, F., Cao, H., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1367 · Cited by 55
Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition
Koshkaryev, A., Piroyan, A., & Torchilin, V. P. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.06.008 · Cited by 54
Alnylam terminates revusiran program, stock plunges
Garber, K. (2016) · Nature Biotechnology · doi:10.1038/nbt1216-1213 · Cited by 53
Tu, Y., & Kim, J. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1184 · Cited by 52
Phage display peptide libraries: deviations from randomness and correctives
Ryvkin, A., Ashkenazy, H., Weiss-Ottolenghi, Y., Piller, C., Pupko, T., & Gershoni, J. M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky077 · Cited by 52
Targeted siRNA delivery using aptamer‐siRNA chimeras and aptamer‐conjugated nanoparticles
Sivakumar, P., Kim, S., Kang, H. C., & Shim, M. S. (2018) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1543 · Cited by 52
García-Díaz, M., Foged, C., & Nielsen, H. M. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.047 · Cited by 51
Tumor-Penetrating Peptides: A Shift from Magic Bullets to Magic Guns
Féron, O. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001174 · Cited by 51
Rengaswamy, V., Zimmer, D., Süss, R., & Rössler, J. K. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.063 · Cited by 50
Brown, A., Patel, S., Ward, C., Lorenz, A. S., Ortiz, M., DuRoss, A. N., Wieghardt, F., Esch, A. M., Otten, E. G., Heiser, L. M., et al. (2016) · Scientific Reports · doi:10.1038/srep31750 · Cited by 48
Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles
Kafshgari, M. H., Alnakhli, M., Delalat, B., Apostolou, S., Harding, F. J., Mäkilä, E. M., Salonen, J., Kuss, B. J., & Voelcker, N. H. (2015) · Biomaterials Science · doi:10.1039/c5bm00204d · Cited by 46
The pH-Triggered Triblock Nanocarrier Enabled Highly Efficient siRNA Delivery for Cancer Therapy
Du, L., Zhou, J., Meng, L., Wang, X., Wang, C., Huang, Y., Zheng, S., Deng, L., Cao, H., Liang, Z., et al. (2017) · Theranostics · doi:10.7150/thno.20297 · Cited by 44
Hegde, V., Hickerson, R. P., Nainamalai, S., Campbell, P. A., Smith, F. J. D., McLean, W. H. I., & Pedrioli, D. M. L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.022 · Cited by 39
Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer
Irimie, A. I., Sonea, L., Jurj, A. M., Mehterov, N. H., Zimța, A., Budişan, L., Braicu, C., & Berindan‐Neagoe, I. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s133219 · Cited by 39
Efficient Delivery of RNA Interference Effectors via In Vitro-Packaged SV40 Pseudovirions
Kimchi‐Sarfaty, C., Brittain, S. M., Garfield, S. H., Caplen, N. J., Tang, Q., & Gottesman, M. M. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1110 · Cited by 35
Targeted gene silencing in human embryonic stem cells using cell-penetrating peptide PepFect 14
Ervin, E.-H., Pook, M., Teino, I., Kasuk, V., Trei, A., Pooga, M., & Maimets, T. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1144-x · Cited by 34
Müller, K., Kessel, E., Klein, P. M., Höhn, M., & Wagner, E. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00102 · Cited by 33
Efficient siRNA delivery with non-cationic carriers
Choi, C. K. K., Zhang, L., & Choi, C. H. J. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0240-z · Cited by 32
Poly(amine-co-ester) nanoparticles for effective Nogo-B knockdown in the liver
Cui, J., Piotrowski-Daspit, A. S., Zhang, J., Shao, M., Bracaglia, L. G., Utsumi, T., Seo, Y.-E., DiRito, J. R., Song, E., Wu, C. J., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.044 · Cited by 32
Allison, S. J., & Milner, J. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.68 · Cited by 31
Zhang, P., Xia, J., & Luo, S. (2018) · Materials · doi:10.3390/ma11040623 · Cited by 31
Fu, A., Zhang, M., Gao, F., Xu, X., & Chen, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059642 · Cited by 28
Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA
Wilner, S. E., & Levy, M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3197-2_18 · Cited by 28
Zhou, A., Du, J., Jiao, M., Xie, D., Wang, Q., Xue, L., Ju, C., Hua, Z., & Zhang, C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.013 · Cited by 25
Design of Highly Potent Lipid-Functionalized Peptidomimetics for Efficient in Vivo siRNA Delivery
Xiao, H. T., Altangerel, A., Gerile, G., Wu, Y., & Baigude, H. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b12144 · Cited by 24
Advances in Lipid-Based Platforms for RNAi Therapeutics
Falsini, S., Ciani, L., Ristori, S., Fortunato, A., & Arcangeli, A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400791q · Cited by 23
Nanoporous Silica-Based Protocells at Multiple Scales for Designs of Life and Nanomedicine
Sun, J., Jakobsson, E., Wang, Y., & Brinker, C. J. (2015) · Life · doi:10.3390/life5010214 · Cited by 21
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Bender, H., Kane, S. J., & Zabel, M. D. (2016) · Journal of Visualized Experiments · doi:10.3791/54106 · Cited by 21
Rabino, I. (2003) · Metamedicine · doi:10.1023/a:1022967623162 · Cited by 19
Cooper, B. M., & Putnam, D. A. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00363 · Cited by 19
Vío, V., Riveros, A. L., Tapia-Bustos, A., Lespay‐Rebolledo, C., Pérez-Lobos, R., Muñoz, L., Pismante, P., Morales, P., Araya, E., Hassan, N., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s175076 · Cited by 14
Therapeutic Applications of RNA Interference: Recent Advances in siRNA Design
Scherer, L. J., & Rossi, J. J. (2004) · Advances in genetics · doi:10.1016/s0065-2660(04)52001-1 · Cited by 11
Efficient in vivo siRNA delivery by stabilized d -peptide-based lipid nanoparticles
Ganbold, T., Gerile, G., Xiao, H. T., & Baigude, H. (2017) · RSC Advances · doi:10.1039/c6ra25862j · Cited by 11
Traumatic brain injury induces transmissible tau pathology
Wood, H. B. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0062-3 · Cited by 7
Kim, B., & Sailor, M. J. (2019) · Journal of Visualized Experiments · doi:10.3791/59440 · Cited by 6
Self-citationMiyake, N., Chikumi, H., Yamaguchi, K., Takata, M., Takata, M., Okada, K., Kitaura, T., Nakamoto, M., & Yamasaki, A. (2019) · Yonago acta medica · doi:10.33160/yam.2019.03.012 · Cited by 5
Cited by
Therapeutic siRNA: state of the art
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586
Therapeutic siRNA: State-of-the-Art and Future Perspectives
Friedrich, M., & Aigner, A. (2022) · BioDrugs · doi:10.1007/s40259-022-00549-3 · Cited by 396
Non-viral vectors for RNA delivery
Yan, Y., Liu, X.-Y., Lu, A., Wang, X.-Y., Jiang, L.-X., & Wang, J.-C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.008 · Cited by 332
DNA hydrogel-based gene editing and drug delivery systems
Mo, F., Jiang, K., Zhao, D., Wang, Y., Song, J., & Tan, W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.018 · Cited by 304
Delfi, M., Sartorius, R., Ashrafizadeh, M., Sharifi, E., Zhang, Y., De Berardinis, P., Zarrabi, A., Varma, R. S., Tay, F. R., Smith, B. R., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101119 · Cited by 253
Metadata
- Authors
- Kim, B., Park, J., & Sailor, M. J.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2019-09-30
- Volume
- 31
- Issue
- 49
- Pages
- e1903637-e1903637
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2977584490
- Cited by
- 298
- References
- 255
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.